In Stock, Ready to Ship!
Original price was: $405.00.$324.00Current price is: $324.00.
The Fat Loss & Metabolic Health Bundle is a comprehensive 4-peptide research stack designed for advanced metabolic studies. This bundle combines GLP receptor signaling, mitochondrial optimization, NAD+ metabolism enhancement, anddirectlipolysisactivationintoasingle, synergisticprotocol. Eachcompound targets a different pathway—creating a multi-angle approach to fat metabolism research without the metabolic crash associated with single-mechanism interventions.
| Peptide | Individual Price |
|---|---|
|
Trinity-X™ (10mg) |
$180.00 |
|
MOTS-c (10mg) |
$85.00 |
|
5-Amino-1MQ (100mg) |
$70.00 |
|
AOD-9604 (10mg) |
$70.00 |
|
TOTAL (If Purchased Separately) |
|
|
BUNDLE PRICE (20% OFF) |
$324.00 |
|
YOU SAVE |
$81.00 |
In Stock, Ready to Ship!
Peptides are not ready to use. Must purchase BAC water for reconstitution.
Trinity-X’s tri-agonist design activates GLP-1, GIP, and glucagon receptors simultaneously, providing comprehensive appetite and metabolic signaling that single-receptor agonists cannot match.
For laboratory research use only. Not for human or animal use.
MOTS-c has been studied for its ability to promote mitochondrial biogenesis and improve oxidative metabolism, potentially increasing the body’s capacity to burn fat as fuel.
For research use only. Not for human consumption or therapeutic application.
5-Amino-1MQ’s NNMT inhibition has been researched for improving NAD+ availability, which plays a crucial role in cellular energy metabolism and may support sustained metabolic output.
For research use only. Not approved for human consumption or clinical use.
AOD-9604’s modified hGH fragment specifically targets fat cells for lipolysis without affecting blood sugar or tissue growth, making it a precision research tool for adipose studies.
This product is for laboratory research use only. Not for human or therapeutic use.
Multiple compounds in this stack (Trinity-X, MOTS-c) have been independently studied for improving insulin sensitivity markers, supporting research into glucose homeostasis and metabolic health.
For research use only. Not for human or veterinary use.
Unlike crash-inducing single-mechanism approaches, this stack’s multi-pathway design has been studied for maintaining metabolic output throughout research protocols without compensatory downregulation.
For research use only. For qualified research personnel only.
The Body Protector Body Protection Compound-157 is a 15-amino acid peptide with one of the broadest healing profiles in peptide research. Studied for remarkable effects on gut, joints, nerves, organs, tendons, ligaments, and virtually every tissue type—BPC-157 is the foundation of any serious regeneration protocol.
The Mitochondrial Optimizer A mitochondrial-derived peptide studied for its role in glucose utilization and mitochondrial fat oxidation. MOTS-c activates AMPK pathways, potentially improving how cells convert fuel into energy while
enhancing insulin sensitivity.
The Fat Mobilizer A small molecule that inhibits NNMT (nicotinamide
N-methyltransferase), studied for enhancing fat mobilization and improving NAD+ economy. By blocking NNMT, 5-Amino-1MQ may help shift cellular metabolism toward increased energy expenditure.
The Lipolysis Signal A modified fragment of human growth hormone (hGH 177-191) specifically studied for direct lipolysis signaling. AOD-9604 targets
fat cells without the broader effects of full hGH, making it a precision tool for adipose tissue research.
Trinity-X’s tri-agonist design activates GLP-1, GIP, and glucagon receptors simultaneously, providing comprehensive appetite and metabolic signaling that single-receptor agonists cannot match.
For laboratory research use only. Not for human or animal use.
MOTS-c has been studied for its ability to promote mitochondrial biogenesis and improve oxidative metabolism, potentially increasing the body’s capacity to burn fat as fuel.
For research use only. Not for human consumption or therapeutic application.
5-Amino-1MQ’s NNMT inhibition has been researched for improving NAD+ availability, which plays a crucial role in cellular energy metabolism and may support sustained metabolic output.
For research use only. Not approved for human consumption or clinical use.
AOD-9604’s modified hGH fragment specifically targets fat cells for lipolysis without affecting blood sugar or tissue growth, making it a precision research tool for adipose studies.
This product is for laboratory research use only. Not for human or therapeutic use.
Multiple compounds in this stack (Trinity-X, MOTS-c) have been independently studied for improving insulin sensitivity markers, supporting research into glucose homeostasis and metabolic health.
For research use only. Not for human or veterinary use.
Unlike crash-inducing single-mechanism approaches, this stack’s multi-pathway design has been studied for maintaining metabolic output throughout research protocols without compensatory downregulation.
For research use only. For qualified research personnel only.
The Fat Loss & Metabolic Health Bundle is a curated 4-peptide research stack specifically designed for comprehensive metabolic studies. Rather than relying on a single mechanism, this bundle combines four distinct pathways:
This multi-angle approach reflects the latest understanding that metabolic health involves interconnected systems—not isolated pathways. By addressing multiple mechanisms simultaneously, researchers can study synergistic effects not achievable with individual compounds.
Researchers choose the Fat Loss & Metabolic Health Bundle when they need a comprehensive protocol for advanced metabolic research. This stack offers:
All peptides are USA-manufactured under cGMP-like conditions, verified to 99% purity, and include full COA/HPLC/MS documentation.
Unlike single-peptide approaches or generic “fat burner” stacks, the Fat Loss & Metabolic Health Bundle is designed with mechanistic synergy in mind:
The Problem with Single-Pathway Approaches: Most fat loss research hits one target—appetite OR metabolism OR lipolysis. The body often compensates by downregulating other pathways, leading to plateaus.
The Multi-Pathway Solution: Thisbundleaddressesthecompensationproblem by simultaneously activating four distinct mechanisms:
The Result: A comprehensive research protocol that mirrors how the body actually regulates energy—through multiple, interconnected systems.
A curated 4-peptide research stack combining Trinity-X, MOTS-c, 5-Amino-
1MQ, and AOD-9604 for comprehensive metabolic and fat loss research studies.
Each peptide targets a different metabolic pathway—GLP signaling, mitochondrial function, NAD+ metabolism, and direct lipolysis—creating synergy not achievable with single compounds.
Trinity-X (formerly GLP-3/Reta) is a tri-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously for comprehensive metabolic signaling.
MOTS-c is a mitochondrial-derived peptide studied for improving glucose utilization, activating AMPK pathways, and enhancing mitochondrial fat oxidation.
5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), which has been studied for enhancing fat mobilization and improving NAD+ availability for cellular energy.
AOD-9604 is a modified fragment of human growth hormone (hGH 177-191) specifically studied for direct lipolysis signaling without broader hGH effects.
Yes. While designed as a synergistic stack, each peptide can be researched individually. The bundle offers cost savings and protocol convenience.
Protocols vary by study design. Common approaches involve daily or weekly administration depending on the compound, with cycle lengths of 8-12 weeks.
Store lyophilized peptides at -20°C. After reconstitution, refrigerate at 2-8°C and use within 14-28 days depending on the specific compound.
Yes. All peptides in this bundle are USA-manufactured under cGMP-like conditions with 99% HPLC-verified purity.
Each peptide includes full COA (Certificate of Analysis), HPLC chromatogram, and Mass Spectrometry documentation.
No. This bundle is sold strictly for laboratory and research purposes only. Not intended for human or veterinary use.
Multi-pathway stacks address the metabolic compensation problem—where the body downregulates one pathway when another is stimulated—by activating multiple mechanisms simultaneously.
Metabolic health studies, obesity research, glucose homeostasis investigations, mitochondrial function assays, and adipose tissue signaling research.
Bacteriostatic water for reconstitution is sold separately. We recommend purchasing BAC water with your bundle order.
End of Content.
